ZA200705392B - Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of HIV-infected patients - Google Patents

Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of HIV-infected patients

Info

Publication number: ZA200705392B
Authority: ZA; South Africa
Prior art keywords: omega; hiv; fatty acid; infected patients; treating hypercholesterolemia
Prior art date: 2004-12-03

Application number

ZA200705392A

Other languages

English (en)

Inventor

Gardette Jean

Original Assignee

Pf Medicament

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-03

Filing date

2007-07-03

Publication date

2008-11-26

2007-07-03 Application filed by Pf Medicament filed Critical Pf Medicament

2008-11-26 Publication of ZA200705392B publication Critical patent/ZA200705392B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Alternative & Traditional Medicine (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Biotechnology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Diabetes (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Marine Sciences & Fisheries (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

ZA200705392A 2004-12-03 2007-07-03 Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of HIV-infected patients ZA200705392B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0412862A FR2878747B1 (fr)	2004-12-03	2004-12-03	Utilisation d'acide(s) gras omega-3 pour le traitement de l'hypercholesterolemie causee par un traitement anti-retroviral chez les patients infectes par le vih

Publications (1)

Publication Number	Publication Date
ZA200705392B true ZA200705392B (en)	2008-11-26

Family

ID=34952290

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200705392A ZA200705392B (en)	2004-12-03	2007-07-03	Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of HIV-infected patients

Country Status (15)

Country	Link
US (1)	US20080113046A1 (xx)
EP (1)	EP1827414A1 (xx)
JP (1)	JP2008521863A (xx)
KR (1)	KR20070089216A (xx)
CN (1)	CN101068542A (xx)
AU (1)	AU2005311266A1 (xx)
BR (1)	BRPI0515823A (xx)
CA (1)	CA2589797A1 (xx)
FR (1)	FR2878747B1 (xx)
IL (1)	IL183349A0 (xx)
MX (1)	MX2007006561A (xx)
NO (1)	NO20073318L (xx)
RU (1)	RU2007123368A (xx)
WO (1)	WO2006058920A1 (xx)
ZA (1)	ZA200705392B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8343753B2 (en)	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
WO2010028067A1 (en)	2008-09-02	2010-03-11	Amarin Corporation Plc	Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
ES2426132T3 (es)	2009-02-10	2013-10-21	Amarin Pharmaceuticals Ireland Limited	Uso del éster etílico del ácido eicosapentaenoico para tratar la hipertrigliceridemia
EP4008327A1 (en)	2009-04-29	2022-06-08	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
DK2424356T3 (en)	2009-04-29	2017-12-04	Amarin Pharmaceuticals Ie Ltd	STABLE PHARMACEUTICAL COMPOSITION AND PROCEDURES FOR USING SAME
AU2016203375B2 (en) *	2009-04-29	2017-11-30	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AU2014200070B2 (en) *	2009-04-29	2016-06-16	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NZ597193A (en)	2009-06-15	2014-01-31	Amarin Pharmaceuticals Ie Ltd	Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
ES2554657T3 (es)	2009-09-23	2015-12-22	Amarin Pharmaceuticals Ireland Limited	Composición farmacéutica que comprende ácido graso omega-3 y derivado hidroxi de una estatina y métodos de uso de la misma
WO2011051743A1 (en)	2009-10-30	2011-05-05	Tharos Ltd.	Solvent-free process for obtaining phospholipids and neutral enriched krill oils
WO2012029898A1 (ja) *	2010-09-01	2012-03-08	日本水産株式会社	アルコール性障害緩和剤
US11712429B2 (en)	2010-11-29	2023-08-01	Amarin Pharmaceuticals Ireland Limited	Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2012074930A2 (en) *	2010-11-29	2012-06-07	Amarin Pharma, Inc.	Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2013070735A1 (en)	2011-11-07	2013-05-16	Amarin Pharmaceuticals Ireland Limited	Methods of treating hypertriglyceridemia
US11291643B2 (en)	2011-11-07	2022-04-05	Amarin Pharmaceuticals Ireland Limited	Methods of treating hypertriglyceridemia
AU2013207368A1 (en)	2012-01-06	2014-07-24	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering levels of high-sensitivity (hs-CRP) in a subject
WO2013192109A1 (en)	2012-06-17	2013-12-27	Matinas Biopharma, Inc.	Omega-3 pentaenoic acid compositions and methods of use
NZ737380A (en)	2012-06-29	2019-05-31	Amarin Pharmaceuticals Ie Ltd	Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US20150258050A1 (en) *	2012-10-23	2015-09-17	Deakin University	Method for reducing triglycerides
US20150265566A1 (en)	2012-11-06	2015-09-24	Amarin Pharmaceuticals Ireland Limited	Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en)	2012-12-31	2014-07-03	Amarin Pharmaceuticals Ireland Limited	Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9814733B2 (en)	2012-12-31	2017-11-14	A,arin Pharmaceuticals Ireland Limited	Compositions comprising EPA and obeticholic acid and methods of use thereof
US9452151B2 (en)	2013-02-06	2016-09-27	Amarin Pharmaceuticals Ireland Limited	Methods of reducing apolipoprotein C-III
US9624492B2 (en)	2013-02-13	2017-04-18	Amarin Pharmaceuticals Ireland Limited	Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en)	2013-02-19	2017-05-30	The Regents Of The University Of Colorado	Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en)	2013-03-14	2016-03-15	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en)	2013-03-15	2014-09-18	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en)	2013-06-06	2021-04-06	Amarin Pharmaceuticals Ireland Limited	Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en)	2013-09-04	2015-03-05	Amarin Pharmaceuticals Ireland Limited	Methods of treating or preventing prostate cancer
US9585859B2 (en)	2013-10-10	2017-03-07	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en)	2014-06-11	2020-02-18	Amarin Pharmaceuticals Ireland Limited	Methods of reducing RLP-C
US10172818B2 (en)	2014-06-16	2019-01-08	Amarin Pharmaceuticals Ireland Limited	Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en)	2016-03-15	2019-09-10	Amarin Pharmaceuticals Ireland Limited	Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en)	2017-05-19	2018-11-22	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en)	2018-03-02	2021-07-13	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
CN111991386A (zh)	2018-09-24	2020-11-27	阿马里纳药物爱尔兰有限公司	降低受试者的心血管事件的风险的方法
CN116350616A (zh)	2019-11-12	2023-06-30	阿马里纳药物爱尔兰有限公司	降低心房纤颤和/或心房扑动受试者心血管事件风险的方法
KR20240012390A (ko)	2021-04-21	2024-01-29	애머린 파마슈티칼스 아일랜드 리미티드	심부전의 위험을 감소시키는 방법
CN114711321B (zh) *	2022-03-19	2024-03-15	浙江新研坤科技有限公司	添加有植物型欧米伽3的南极磷虾油凝胶糖果及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5141923A (en) *	1990-12-31	1992-08-25	Immunology, Inc., A California Corporation	Methods for the treatment of retroviral infections
GB9503850D0 (en) *	1995-02-25	1995-04-19	Glaxo Group Ltd	Medicaments
US6511983B1 (en) *	1999-03-01	2003-01-28	Biochem Pharma Inc.	Pharmaceutical combination of antiviral agents
DE19956400B4 (de) *	1999-11-24	2005-09-08	Sagredos, Angelos, Prof. Dr.	Therapeutisch wirksame Zusammensetzung, ein Verfahren zu ihrer Herstellung und ihre Verwendung
EP1157692B1 (en) *	2000-05-22	2005-10-05	Pro Aparts - Investimentos E Consultoria Lda	Composition of fatty acids containing at least 80% by weight of EPA and DHA or their derivatives and its pharmaceutical use
US8017651B2 (en) *	2002-11-22	2011-09-13	Bionexus, Ltd.	Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia

2004
- 2004-12-03 FR FR0412862A patent/FR2878747B1/fr not_active Expired - Fee Related
2005
- 2005-12-02 MX MX2007006561A patent/MX2007006561A/es unknown
- 2005-12-02 CN CNA2005800412354A patent/CN101068542A/zh active Pending
- 2005-12-02 CA CA002589797A patent/CA2589797A1/fr not_active Abandoned
- 2005-12-02 AU AU2005311266A patent/AU2005311266A1/en not_active Abandoned
- 2005-12-02 JP JP2007543861A patent/JP2008521863A/ja not_active Abandoned
- 2005-12-02 KR KR1020077015265A patent/KR20070089216A/ko not_active Ceased
- 2005-12-02 US US11/792,060 patent/US20080113046A1/en not_active Abandoned
- 2005-12-02 RU RU2007123368/15A patent/RU2007123368A/ru not_active Application Discontinuation
- 2005-12-02 BR BRPI0515823-0A patent/BRPI0515823A/pt not_active IP Right Cessation
- 2005-12-02 WO PCT/EP2005/056431 patent/WO2006058920A1/fr not_active Ceased
- 2005-12-02 EP EP05816108A patent/EP1827414A1/fr not_active Withdrawn
2007
- 2007-05-21 IL IL183349A patent/IL183349A0/en unknown
- 2007-06-27 NO NO20073318A patent/NO20073318L/no not_active Application Discontinuation
- 2007-07-03 ZA ZA200705392A patent/ZA200705392B/xx unknown

Also Published As

Publication number	Publication date
IL183349A0 (en)	2008-04-13
BRPI0515823A (pt)	2008-08-05
JP2008521863A (ja)	2008-06-26
MX2007006561A (es)	2007-06-15
AU2005311266A1 (en)	2006-06-08
RU2007123368A (ru)	2009-01-10
CA2589797A1 (fr)	2006-06-08
NO20073318L (no)	2007-06-27
CN101068542A (zh)	2007-11-07
US20080113046A1 (en)	2008-05-15
KR20070089216A (ko)	2007-08-30
EP1827414A1 (fr)	2007-09-05
WO2006058920A1 (fr)	2006-06-08
FR2878747B1 (fr)	2007-03-30
FR2878747A1 (fr)	2006-06-09

Publication	Publication Date	Title
IL183349A0 (en)	2008-04-13	Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of hiv-infected patients
GB0715745D0 (en)	2007-09-19	Liquid formulations for treatment of diseases or conditions
EP1744751A4 (en)	2010-03-10	METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
EP2450046A4 (en)	2013-07-03	MEDICAL COMPOSITION FOR THE TREATMENT OF BRONCHITIS AND THEIR MANUFACTURE
EP1755584A4 (en)	2007-10-31	Treatment of myopia
EP2059210A4 (en)	2013-01-09	THERAPEUTIC DEVICES FOR TREATING VARIOUS WOMEN'S DRESS
GB0522311D0 (en)	2005-12-07	Pharmaceutical compositions for the treatment of pain
EP2187743A4 (en)	2010-10-27	FORMULATIONS FOR THE TREATMENT OF DISEASES OR EYE DISORDERS
ZA200903862B (en)	2010-05-26	Nutritional supplement composition for treatment of ocular diseases
PL2056863T3 (pl)	2017-11-30	Leczenie chorób oczu
EP1536834A4 (en)	2007-11-07	DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES
ITPD20050266A1 (it)	2007-03-16	Apparato per il trattamento di patologie di origine malformativa e traumatica afferenti l'area del ginocchio
EP2091480A4 (en)	2011-04-13	SYSTEM FOR THE TREATMENT OF HEART TISSUE
FI20095600L (fi)	2009-06-09	Koostumus ihosairauksien hoitoa varten
EP1786471A4 (en)	2008-01-23	Treating cardiovascular tissue
ZA200808363B (en)	2009-12-30	Compounds and methods for diagnosis and treatment of leishmaniasis
UA85471C2 (ru)	2009-01-26	Применение оксикодона для лечения висцеральной боли
FR2860154B1 (fr)	2006-02-03	Composition pour le traitement de la mauvaise haleine
PL1881824T3 (pl)	2015-06-30	Zastosowanie triglicerydów kwasu dokozaheksaenowego w leczeniu chorób nowotworowych
EP1732549A4 (en)	2009-11-11	METHOD FOR THE TREATMENT OF SYNUCLEINOPATHIES
EP1745737A4 (en)	2010-09-01	TREATMENT INSTRUMENT FOR AN ENDOSCOPE
EP1788936A4 (en)	2010-10-06	CATHETER DEVICE FOR THE TREATMENT OF HERZARRHYTHMIA
TWI365753B (en)	2012-06-11	Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases
EP2220057A4 (en)	2011-10-12	PROSTAGLANDIN E1 AND E2 ANALOGUES FOR THE TREATMENT OF VARIOUS MEDICAL CONDITIONS
EP1846013A4 (en)	2009-09-09	TREATMENT OF SKIN DISEASES